hiv-infections

Documents about hiv-infections

• Guidelines on HIV self-testing and partner notification: supplement to consolidated guidelines on HIV testing services#373054WHO IRIS
• Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants#390973ClinicalTrials.gov
• A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 Gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected Adults#417584ClinicalTrials.gov
• A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals#444763ClinicalTrials.gov
• Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa#454083ClinicalTrials.gov
• Guidelines for nursing management of people infected with human immunodeficiency virus (HIV)#466862WHO IRIS
• Antibodies and Memory Cells Role After Different Pneumococcal Vaccines in HIV Adults#838600ClinicalTrials.gov
• A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)#840996ClinicalTrials.gov
• Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration#843708ClinicalTrials.gov
• Our Healthbox - Evaluating Interactive Dispensing Systems for Low-Barrier Access to HIV Testing and Harm Reduction.#850828ClinicalTrials.gov
• Rapid HIV Tests for Women Late in Pregnancy and During Labor#869268ClinicalTrials.gov
• Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women#872687ClinicalTrials.gov
• The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects#875463ClinicalTrials.gov
• Association of HIV status with infections complicating abortion in Botswana.#247645NCBI PubMed Central
• A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines#394602ClinicalTrials.gov
• Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022–2030: 2026 mid-term progress report#401516WHO IRIS
• A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients#853901ClinicalTrials.gov
• Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants.#226344ClinicalTrials.gov
• Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic Mix#467630ClinicalTrials.gov
• Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents#481784ClinicalTrials.gov
• HIV infection and AIDS : guidelines for nursing care#632343WHO IRIS
• VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients#824813ClinicalTrials.gov
• Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru#840606ClinicalTrials.gov
• Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V Mutation#844144ClinicalTrials.gov
• Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants#865716ClinicalTrials.gov
• Improving HIV Prevention and Substance Use Post-Sexual Assault Services#877233ClinicalTrials.gov
• Examining the Link Between Heart Disease and HIV Infection in Women#888165ClinicalTrials.gov
• GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study#900964ClinicalTrials.gov
• Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products#903954ClinicalTrials.gov
• Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs#803745ClinicalTrials.gov
• A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients#865978ClinicalTrials.gov
• Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs#885815ClinicalTrials.gov
• The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs#891762ClinicalTrials.gov
• Stressful life events, PTSD symptoms and mental health in people living with HIV: Correlates of trauma in people with HIV.#9830PubMed
• Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected Adults#152498ClinicalTrials.gov
• Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults#195408ClinicalTrials.gov
• Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy#217095ClinicalTrials.gov
• Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults#234485ClinicalTrials.gov
• Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance#474886ClinicalTrials.gov
• Ethical Challenges Posed by HIV-Vaccine Induced Seropositivity for the Informed Consent Process and HIV Testing Practices in Maputo City, Mozambique.#679686PubMed
• Transmasculine One-on-One and Group Empowerment for Targeted HIV Reduction#800678ClinicalTrials.gov
• HIV Viral Load Monitoring in Resource-Poor Settings#860503ClinicalTrials.gov
• Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis#867575ClinicalTrials.gov
• Behavioral Intervention to Reduce Sexual and Injection Risks Among Female Sex Workers Who Also Inject Drugs in Mexico#883180ClinicalTrials.gov
• Policy guidelines for collaborative TB and HIV services for injecting and other drug users : an integrated approach#381554WHO IRIS
• HIV and adolescents: guidance for HIV testing and counselling and care for adolescents living with HIV : annex 4: systematic review – ALHIV: Disclosure, adherence and retention in care#381552WHO IRIS
• A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection#868894ClinicalTrials.gov
• A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules#836046ClinicalTrials.gov
• Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact: web annex G: sampling, abstraction and reporting guidance for early warning indicators of HIV drug resistance#379677WHO IRIS
• A PK and Salvage Study for Children With HIV-infection#845647ClinicalTrials.gov